Value of inflammatory markers for monitoring disease severity and progression in granuloma induced by cosmetic oil injections
Bone · 2025
DOI: 10.1016/j.bone.2025.117500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2025. Verfasst von Ida Enggaard Kaae und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen University Hospital - Herlev and Gentofte, Den…. Hauptthemen laut MEDLINE: Biomarkers, Disease Progression, Inflammation, Oils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Cosmetic oil injections can cause foreign body granulomas, leading to inflammation-driven extrarenal production of activated vitamin D (1,25(OH)2D3) and severe hypercalcemia. This study investigates longitudinal changes in inflammatory markers: interleukin 2 receptor (IL-2R), peptidyl dipeptidase (ACE), and ferritin in patients with oil-induced granuloma. MATERIALS AND METHODS: 109 male patients were stratified according to baseline calcium status. 28 % had hypercalcemia, and 72 % normocalcemia. Normocalcemic patients were subdivided based on serum parathyroid hormone (PTH) concentrations into suppressed (< 2.0 pmol/L, n = 30) or normal (≥ 2.0 pmol/L, n = 49) concentrations. Blood samples were collected over 48 months and longitudinal changes in inflammatory markers and calcium homeostasis were examined using Pearson correlation and mixed model analyses. RESULTS: IL-2R, ACE, and ferritin were positively correlated with serum concentration of ionized calcium, while IL-2R was associated with serum 1,25(OH)2D3. In patients with hypercalcemia, IL-2R decreased at 6 (p = 0.041), 24 (p = 0.048), and 36 months (p = 0.035). ACE increased at 48 months (p = 0.008). In patients with normocalcemia and suppressed PTH, IL-2R increased at 24 months (p = 0.021), while serum ferritin increased in patients with normocalcemia and normal PTH at 6 (p = 0.040), 12 (p = 0.008), 24 (p = 0.028), and 48 months (p = 0.005). CONCLUSIONS: Positive correlations were observed at baseline between ionized calcium concentrations and IL-2R, ionized calcium and ferritin, and 1,25(OH)₂D₃ and IL-2R. Hypercalcemia and suppressed PTH was associated with elevated IL-2R and ferritin concentrations at baseline. Over time, IL-2R and ferritin concentrations decreased in patients with hypercalcemia, some treated with immunomodulatory drugs. IL-2R and ferritin concentrations increased in untreated patients with normocalcemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.
- Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark; Group of Skeletal, Mineral and Gonadal Endocrinology, Department…
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Endocrinology, Herlev-Gentofte University Hospital, Copenhagen, Denmark. Electronic address: ebbe.eldrup@regionh.dk.
Zitieren
APA
Kaae, I. E., Yahyavi, S. K., Blomberg Jensen, M., & Eldrup, E. (2025). Value of inflammatory markers for monitoring disease severity and progression in granuloma induced by cosmetic oil injections. Bone. https://doi.org/10.1016/j.bone.2025.117500
Vancouver
Kaae IE, Yahyavi SK, Blomberg Jensen M, Eldrup E. Value of inflammatory markers for monitoring disease severity and progression in granuloma induced by cosmetic oil injections. Bone. 2025. doi:10.1016/j.bone.2025.117500
BibTeX
@article{Kaae2025,
author = {Kaae, Ida Enggaard and Yahyavi, Sam Kafai and Blomberg Jensen, Martin and Eldrup, Ebbe},
title = {Value of inflammatory markers for monitoring disease severity and progression in granuloma induced by cosmetic oil injections},
journal = {Bone},
year = {2025},
doi = {10.1016/j.bone.2025.117500}
}
EUVIMED